Home
About
Overview
Sharing Data
ORCID
Help
History (32)
rho Guanine Nucleotide Dissociation Inhibitor gamma
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22.
Targeting the transforming growth factor-ß pathway: a novel mechanism of ulipristal acetate action against uterine fibroids.
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer.
Principal Investigator
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Prendergast, Brian
contributes to
Biological Rhythms and Immune Function